We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-11.75%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$112B
AUM Growth
-$20.7B
(-16%)
Cap. Flow
-$1.85B
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
32.05%
Holding
345
New
6
Increased
51
Reduced
230
Closed
4
Avg Time Held
5.3
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
5.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$231M |
| 2 |
Walt Disney
DIS
|
+$216M |
| 3 |
Raymond James Financial
RJF
|
+$191M |
| 4 |
Oracle
ORCL
|
+$124M |
| 5 |
Delta Air Lines
DAL
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles Schwab
SCHW
|
+$447M |
| 2 |
Amazon
AMZN
|
+$368M |
| 3 |
Microsoft
MSFT
|
+$206M |
| 4 |
Bank of America
BAC
|
+$149M |
| 5 |
Eli Lilly
LLY
|
+$130M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.19% |
| 2 | Technology | 27.99% |
| 3 | Industrials | 11.8% |
| 4 | Consumer Discretionary | 9.37% |
| 5 | Financials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
OraSure Technologies
OSUR
$263M
| $2.48M | ﹤0.01% |
913,400
-45,600
| -5% | -$227K |
2013 Q2
36 quarters
|
|
302
DELISTED
Jamf
JAMF
| $2.41M | ﹤0.01% |
97,300
-5,700
| -6% | -$160K |
2021 Q2
4 quarters
|
|
303
JELD-WEN Holding
JELD
$118M
| $2.39M | ﹤0.01% |
163,900
+2,000
| +1% | +$36.3K |
2021 Q1
5 quarters
|
|
304
Nokia
NOK
$53.6B
| $2.31M | ﹤0.01% |
500,000
-40,000
| -7% | -$200K |
2019 Q2
12 quarters
|
|
305
DELISTED
Safehold Inc.
SAFE
| $1.92M | ﹤0.01% |
54,400
| – | – |
2020 Q4
6 quarters
|
|
306
Prestige Consumer Healthcare
PBH
$2.33B
| $1.85M | ﹤0.01% |
31,400
| – | – |
2017 Q4
18 quarters
|
|
307
Snap
SNAP
$10.9B
| $1.79M | ﹤0.01% |
136,550
-111,000
| -45% | -$2.53M |
2020 Q2
8 quarters
|
|
|
MBII
308
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $1.69M | ﹤0.01% |
1,458,400
-60,700
| -4% | -$63.5K |
2013 Q3
35 quarters
|
|
309
Greif Class B
GEF.B
$4.18B
| $1.62M | ﹤0.01% |
26,000
-2,000
| -7% | -$120K |
2013 Q2
36 quarters
|
|
310
Marqeta
MQ
$1.98B
| $1.61M | ﹤0.01% |
49,675
+5,875
| +13% | +$231K |
2021 Q3
3 quarters
|
|
311
DELISTED
Faro Technologies
FARO
| $1.53M | ﹤0.01% |
49,500
-8,930
| -15% | -$327K |
2013 Q2
36 quarters
|
|
312
DELISTED
Calavo Growers
CVGW
| $1.5M | ﹤0.01% |
35,900
| – | – |
2017 Q3
19 quarters
|
|
313
Okta
OKTA
$36.5B
| $1.44M | ﹤0.01% |
15,925
+5,000
| +46% | +$540K |
2020 Q1
9 quarters
|
|
314
DELISTED
Sun Country Airlines
SNCY
| $1.37M | ﹤0.01% |
74,815
-600
| -0.8% | -$14K |
2021 Q1
5 quarters
|
|
315
Varonis Systems
VRNS
$5.44B
| $1.35M | ﹤0.01% |
45,940
-1,570
| -3% | -$58.4K |
2022 Q1
1 quarter
|
|
316
Adaptive Biotechnologies
ADPT
$4.08B
| $1.22M | ﹤0.01% |
150,500
-45,000
| -23% | -$396K |
2020 Q1
9 quarters
|
|
317
Kroger
KR
$37B
| $1.18M | ﹤0.01% |
25,000
| – | – |
2021 Q4
2 quarters
|
|
318
Arbutus Biopharma
ABUS
$850M
| $1.15M | ﹤0.01% |
423,300
-37,700
| -8% | -$96.5K |
2015 Q1
29 quarters
|
|
|
CALA
319
DELISTED
Calithera Biosciences, Inc
CALA
| $1.03M | ﹤0.01% |
420,280
-116,370
| -22% | -$539K |
2019 Q4
10 quarters
|
|
320
Madison Square Garden
MSGS
$9.74B
| $1.02M | ﹤0.01% |
6,773
| – | – |
2020 Q1
9 quarters
|
|
321
Celanese
CE
$5.1B
| $941K | ﹤0.01% |
8,000
| – | – |
2013 Q2
36 quarters
|
|
322
Accuray
ARAY
$20.8M
| $845K | ﹤0.01% |
431,320
-35,280
| -8% | -$88.1K |
2013 Q2
36 quarters
|
|
323
Bloom Energy
BE
$69.6B
| $818K | ﹤0.01% |
49,600
| – | – |
2019 Q3
11 quarters
|
|
|
TSP
324
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $787K | ﹤0.01% |
108,800
-19,300
| -15% | -$176K |
2021 Q2
4 quarters
|
|
325
DELISTED
2U Inc
TWOU
| $785K | ﹤0.01% |
2,500
| – | – |
2019 Q2
12 quarters
|
|
Similar funds
Primecap Management's Q2 2022 Portfolio in Review
As of Q2 2022, Primecap Management held 345 positions worth $112B, down 16% from $133B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 2.9%. Primecap Management opened 6 new positions and exited 4, leaving the 345-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.
- Primecap Management's largest Q2 2022 buy was Array Technologies: 2,382,600 shares worth $26.2M.
- Primecap Management added most to Intel in Q2 2022, an estimated $231M increase.
- Primecap Management's biggest Q2 2022 reduction was Charles Schwab, cutting an estimated $447M.
- Primecap Management fully exited Chegg in Q2 2022, selling an estimated $49.6M.
- Primecap Management's ten largest holdings make up 32% of its $112B portfolio in Q2 2022.
- Primecap Management opened 6 new positions and closed 4 in Q2 2022.
- Primecap Management's portfolio value fell 16% quarter-over-quarter to $112B.
Based on Primecap Management's 13F filing for Q2 2022, filed 11 Aug 2022.